NCT00421980View on ClinicalTrials.gov

An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis

PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

June 30, 2002

Study Completion Date

July 31, 2004

Conditions
Ankylosing Spondylitis
Interventions
DRUG

Etanercept

Trial Locations (1)

09000

Ghent

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00421980 - An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter